ClassID:

21256

A61K45/06 - page 24 - CPC Classification

Classification description:

Medicinal preparations containing active ingredients not provided for in groups  -  Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Recent Application in this class:
#6901
20230349899
2023-11-02

METHODS AND COMPOSITIONS RELATING TO ASSESSMENT FOR INFERTILITY

#6902
20230348988
2023-11-02

DNA Damage Repair Deficit in Cancer Cells

#6903
20230348903
2023-11-02

OLIGONUCLEOTIDES

#6904
20230348615
2023-11-02

Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses

#6905
20230348611
2023-11-02

OBINUTUZUMAB TREATMENT OF A DLBCL PATIENT SUBGROUP

#6906
20230348599
2023-11-02

METHODS FOR TREATING GLIOBLASTOMA

#6907
20230348585
2023-11-02

METHODS FOR TREATING OR REDUCING THE SEVERITY OF A VIRAL INFECTION

#6908
20230348584
2023-11-02

USE OF ANTI-FAM19A5 ANTIBODIES FOR TREATING CANCERS

#6909
20230348579
2023-11-02

DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATING C5-MEDIATED GLOMERULAR NEPHRITIS (GN), INCLUDING LUPUS NEPHRITIS (LN) AND/OR IGA NEPHROPATHY (IGAN)

#6910
20230348569
2023-11-02

Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments

#6911
20230348563
2023-11-02

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

#6912
20230348559
2023-11-02

NOVEL T-CELL SPECIFICITIES AND USES THEREOF

#6913
20230348534
2023-11-02

SAP AND PEPTIDOMIMETICS FOR TREATMENT OF EYE DISEASE

#6914
20230348501
2023-11-02

Heteroaryl inhibitors of PDE4

#6915
20230348495
2023-11-02

A COMPOUND HAVING INHIBITORY ACTIVITY AGAINST KRAS G12D MUTATION

#6916
20230348494
2023-11-02

MCL1 inhibitors

#6917
20230348476
2023-11-02

CBP/CATENIN SIGNALING PATHWAY INHIBITORS AND USES THEREOF

#6918
20230348458
2023-11-02

NLRP3 MODULATORS

#6919
20230348435
2023-11-02

1-((1H-PYRAZOL-4-YL)METHYL)-3-(PHENYL)-1,3-DIHYDRO-2H-IMIDAZOL-2-ONE DERIVATIVES AND RELATED COMPOUNDS AS GPR139 ANTAGONISTS FOR THE TREATMENT OF E.G. DEPRESSION

#6920
20230348428
2023-11-02

PLASMA KALLIKREIN INHIBITORS

#6921
20230348419
2023-11-02

BIAMINOQUINOLINES AND NANOFORMULATIONS FOR CANCER TREATMENT

#6922
20230348383
2023-11-02

CRYSTALLINE 5-METHOXY-N,N-DIALLYLTRYPTAMINE COMPOUNDS

#6923
20230348377
2023-11-02

PURE FORMS OF CRYSTALLINE ATICAPRANT

#6924
20230348362
2023-11-02

LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS

#6925
20230346972
2023-11-02

Biomimetic vesicles and uses thereof

#6926
20230346928
2023-11-02

MRNA COMBINATION THERAPY FOR THE TREATMENT OF CANCER

#6927
20230346926
2023-11-02

METHODS OF TREATING ANKYLOSING SPONDYLITIS USING IL-17 ANTAGONISTS

#6928
20230346897
2023-11-02

METHOD AND DRUG FOR PROMOTING DEGRADATION OF MISFOLDED PROTEIN AND AGGREGATE THEREOF

#6929
20230346891
2023-11-02

Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the same

#6930
20230346890
2023-11-02

Treatment of hyperinsulinemic hypoglycemia with GLP-1 antagonist exendin(9-39)

#6931
20230346888
2023-11-02

METHOD AND COMPOSITION OF TREATMENT OR PREVENTION OF CORONAVIRUS INFECTION

#6932
20230346883
2023-11-02

COMPOSITIONS FOR AND METHODS OF TREATMENT WITH MUTANT A1 ADENOSINE RECEPTOR PLASMID cDNAs

#6933
20230346874
2023-11-02

METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPHTHALMIC CONDITIONS

#6934
20230346873
2023-11-02

Enhanced Mediterranean Diet-Based Nutritional Compositions And Methods

#6935
20230346872
2023-11-02

TREATMENT AND PREVENTION OF CORONAVIRUS INFECTION

#6936
20230346869
2023-11-02

FORMULATION FOR MANAGEMENT OF POST-ORAL SURGICAL RECOVERY AND MAINTENANCE OF ORAL HEALTH

#6937
20230346862
2023-11-02

CANCER ERADICATING - BIO-NANOPARTICLES (CE-BNP)

#6938
20230346850
2023-11-02

Therapeutic Bacterial Composition

#6939
20230346847
2023-11-02

JUVENILE PROTECTIVE FACTORS TO ARREST AND REVERSE AGING IN THE ENTERIC NERVOUS SYSTEM

#6940
20230346831
2023-11-02

METHODS FOR TREATING METASTATIC CANCER USING LOW DOSE CARBON MONOXIDE

#6941
20230346816
2023-11-02

COMPOUNDS AND METHODS FOR TREATING VIRAL INFECTION

#6942
20230346815
2023-11-02

LMP7-SELECTIVE INHIBITORS FOR THE TREATMENT OF BLOOD DISORDERS AND SOLID TUMORS

#6943
20230346809
2023-11-02

USE OF CANNABIDIVARIN IN THE TREATMENT OF SEIZURES ASSOCIATED WITH RARE EPILEPSY SYNDROMES RELATED TO GENETIC ABNORMALITIES

#6944
20230346801
2023-11-02

USE OF AGENTS FOR TREATMENT OF RESPIRATORY CONDITIONS

#6945
20230346798
2023-11-02

Use of zinc porphyrin as an antimicrobial

#6946
20230346797
2023-11-02

INHIBITORS OF THE PLASMODIAL SURFACE ANION CHANNEL AS ANTIMALARIALS

#6947
20230346796
2023-11-02

Dosing regimen for sedation with CNS 7056 (Remimazolam)

#6948
20230346794
2023-11-02

Administration and dosage of diaminophenothiazines

#6949
20230346793
2023-11-02

Compositions and Methods for Treating SARS-CoV-2

#6950
20230346791
2023-11-02

ATR INHIBITORS FOR THE TREATMENT OF CANCER

#6951
20230346788
2023-11-02

METHODS FOR TREATING VIRAL DISORDERS

#6952
20230346787
2023-11-02

Organic compounds

#6953
20230346784
2023-11-02

METHOD FOR TREATING COMPLEMENT MEDIATED DISORDERS CAUSED BY BETACORONAVIRUSES

#6954
20230346783
2023-11-02

THERAPEUTIC STRATEGIES TO MANAGE FACIAL CONTRACTURES POST INJURY

#6955
20230346777
2023-11-02

USE OF SGC ACTIVATORS FOR THE TREATMENT OF OPHTHALMOLOGIC DISEASES

#6956
20230346769
2023-11-02

USE OF SIMPLE ACYCLIC POLYAMINES FOR THE TREATMENT OF DISEASES CAUSED BY PARASITES OF THE GENUS LEISHMANIA

#6957
20230346767
2023-11-02

Nicotine lozenge

#6958
20230346761
2023-11-02

REPURPOSING FDA-APPROVED DRUGS AS A NOVEL CANCER THERAPEUTIC AVENUE THROUGH INHIBITION OF PRMT5

#6959
20230346760
2023-11-02

AGENTS TO PREVENT TISSUE DAMAGE FROM CLOSTRIDIUM DIFFICILE INFECTIONS BY INHIBITION OF THE GUT-DAMAGING BACTERIAL TOXINS TCDA AND TCDB

#6960
20230346753
2023-11-02

NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT

#6961
20230346750
2023-11-02

5HT AGONISTS FOR TREATING DISORDERS

#6962
20230346748
2023-11-02

PHARMACEUTICAL COMBINATION, COMPOSITION AND COMPOUND PREPARATION CONTAINING GLUCOKINASE ACTIVATOR AND K-ATP CHANNEL BLOCKER, PREPARATION METHOD THEREFOR AND USE THEREOF

#6963
20230346741
2023-11-02

ERIODICTYOL COMPOSITIONS AND METHODS

#6964
20230346737
2023-11-02

COMPOUNDS AND METHODS FOR PREVENTION AND TREATMENT OF VIRUS INFECTIONS

#6965
20230346734
2023-11-02

COMBINATION THERAPY OF ATRA OR OTHER RETINOIDS WITH IMMUNOTHERAPEUTIC AGENTS BINDING TO BCMA

#6966
20230346728
2023-11-02

Methods of Treatment of Inflammation Related Conditions Using Pluripotent Anti-Inflammatory and Metabolic Modulators

#6967
20230346706
2023-11-02

BIOLOGICALLY ACTIVE SUBSTANCE UNIFORMLY DISPERSED MICROSPHERE AND A SUSTAINED RELEASE FORMULATION COMPRISING THE SAME

#6968
20230346697
2023-11-02

Antimicrobial and anti-inflammatory compositions

#6969
20230346690
2023-11-02

Method and Formulation for Improving Roflumilast Skin Penetration Lag Time

#6970
20230346689
2023-11-02

Method and Formulation for Improving Roflumilast Skin Penetration Lag Time

#6971
20230346645
2023-11-02

METHOD OF TITRATING DOSE OF PSYCHEDELICS

#6972
20230345938
2023-11-02

SYNERGISTIC ANTIBACTERIAL ACTIVITY OF MEDIUM POLARITY OILS IN COMBINATION WITH ANTIBACTERIAL AGENTS ON BACTERIAL BIOFILMS

#6973
20230341377
2023-10-26

DISCONNECTION AGENTS

#6974
20230341375
2023-10-26

METHODS FOR TREATING MULTIPLE MYELOMA AND THE USE OF COMPANION BIOMARKERS FOR 4-(4-(4-(((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-4-YL)OXY)METHYL)BENZYL)PIPERAZIN-1-YL)-3-FLUOROBENZONITRILE

#6975
20230340625
2023-10-26

METHOD AND SYSTEM FOR DETECTING AND TREATING EXPOSURE TO AN INFECTIOUS PATHOGEN

#6976
20230340613
2023-10-26

METHODS FOR MONITORING AND TREATING CANCER

#6977
20230340488
2023-10-26

TREATMENT OF SKIN DISEASES AND DISORDERS USING INHIBITORS OF KALLIKREIN-RELATED PEPTIDASES (KLK)

#6978
20230340479
2023-10-26

Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereof

#6979
20230340151
2023-10-26

Antibodies specific for GUCY2c and uses thereof

#6980
20230340148
2023-10-26

METHOD FOR TREATING A GD2 POSITIVE CANCER

#6981
20230340143
2023-10-26

COMPOSITIONS AND METHODS FOR TREATING CANCER

#6982
20230340127
2023-10-26

METHODS AND COMPOSITIONS FOR CANCER TREATMENT BY INHIBITION OF FBXO44

#6983
20230340123
2023-10-26

BTLA-BINDING ANTIBODIES FOR MODULATING IMMUNE RESPONSE AND TREATING DISEASE

#6984
20230340119
2023-10-26

COMPOSITION OF TRIAX ANTIBODIES AND METHOD OF MAKING AND USING THEREOF

#6985
20230340118
2023-10-26

ANTI-CD147 ANTIBODY

#6986
20230340114
2023-10-26

NOVEL ANTI-LILRB4 ANTIBODIES AND DERIVATIVE PRODUCTS

#6987
20230340090
2023-10-26

Misfolded TDP-43 Binding Molecules

#6988
20230340087
2023-10-26

YEAST-BASED IMMUNOTHERAPY AGAINST CLOSTRIDIUM DIFFICILE INFECTION

#6989
20230340086
2023-10-26

ANTIBODY-MEDIATED NEUTRALIZATION OF BETA-LACTAMASES

#6990
20230340081
2023-10-26

ANTI-HBV ANTIBODIES AND METHODS OF USE

#6991
20230340078
2023-10-26

TREATMENT OF HEREDITARY ANGIOEDEMA WITH LIVER-SPECIFIC GENE THERAPY VECTORS

#6992
20230340068
2023-10-26

CHIMERIC ANTIGEN RECEPTOR (CAR) WITH CD28 TRANSMEMBRANE DOMAIN

#6993
20230340061
2023-10-26

PEPTIDES AND METHODS FOR THE TREATMENT OF MULTIPLE SCLEROSIS

#6994
20230340033
2023-10-26

Immunogenic Compositions Against SARS-COV-2 Variants And Their Methods Of Use

#6995
20230340025
2023-10-26

Treatments for Gastrointestinal Disorders

#6996
20230340006
2023-10-26

DPAGT1 INHIBITORS OF CAPURAMYCIN ANALOGUES AND THEIR ANTIMIGRATORY ACTIVITIES OF SOLID TUMORS

#6997
20230340003
2023-10-26

Processes for the preparation of soluble salts of inositol phosphates

#6998
20230339991
2023-10-26

HYPOXIA-ACTIVATED DNA ALKYLATING AGENT AND MEDICAL USE THEREOF

#6999
20230339977
2023-10-26

SUBSTITUTED HETEROARYL COMPOUND, AND COMPOSITION AND APPLICATION THEREOF

#7000
20230339972
2023-10-26

Bridged tricyclic carbamoylpyridone compounds and uses thereof

#7001
20230339971
2023-10-26

Bridged tricyclic carbamoylpyridone compounds and uses thereof

#7002
20230339960
2023-10-26

Bicyclic-fused heteroaryl or aryl compounds

#7003
20230339952
2023-10-26

Macrocyclic heterocycles and uses thereof

#7004
20230339929
2023-10-26

THERAPEUTIC AGENTS AND METHODS OF TREATMENT

#7005
20230339896
2023-10-26

HPK1 INHIBITORS AND USES THEREOF

#7006
20230339871
2023-10-26

COMPOUNDS AND METHODS OF MODULATING 17B-HYDROXYSTEROID DEHYDROGENASE TYPE 13

#7007
20230339865
2023-10-26

QUINAZOLINE-DERIVED HCK INHIBITORS FOR USE IN THE TREATMENT OF MYD88 MUTATED DISEASES

#7008
20230338617
2023-10-26

METHODS AND COMPOSITIONS FOR REPAIR OF CARTILAGE USING AN IN VIVO BIOREACTOR

#7009
20230338587
2023-10-26

METHOD OF TREATING PSMA-EXPRESSING CANCERS

#7010
20230338579
2023-10-26

RNA CONTAINING COMPOSITION FOR TREATMENT OF TUMOR DISEASES

#7011
20230338554
2023-10-26

GALACTOSYLATED DENDRIMERS FOR TARGETED INTRACELLULAR DELIVERY TO HEPATOCYTES

#7012
20230338553
2023-10-26

DELIVERY SYSTEM FOR TARGETED DELIVERY OF A THERAPEUTICALLY ACTIVE PAYLOAD

#7013
20230338543
2023-10-26

GAMMA-HYDROXYBUTYRATE DELIVERING COMPOUNDS AND PROCESSES FOR MAKING AND USING THEM

#7014
20230338540
2023-10-26

XANTHAN-BASED OPHTHALMIC TOPICAL FORMULATIONS WITH A REDUCED DOSAGE REGIMEN

#7015
20230338525
2023-10-26

VISTA MODULATORS FOR DIAGNOSIS AND TREATMENT OF CANCER

#7016
20230338520
2023-10-26

Method of treating, reducing, or alleviating a medical condition in a patient

#7017
20230338512
2023-10-26

Coronavirus vaccine

#7018
20230338505
2023-10-26

Immune complex

#7019
20230338492
2023-10-26

ALDH1 ANTIGEN-PULSED DENDRITIC CELLS

#7020
20230338475
2023-10-26

USE OF INHALED INTERFERON-BETA TO IMPROVE OUTCOME IN SARS-CoV-2 INFECTED PATIENTS

#7021
20230338467
2023-10-26

METHODS AND COMPOSITIONS FOR TREATING CARDIOVASCULAR DISEASES USING FAT SPECIFIC PROTEIN 27 (FSP27) COMPOSITIONS

#7022
20230338459
2023-10-26

Treatment for Diseases Caused by RNA Viruses

#7023
20230338458
2023-10-26

COLLAGEN PEPTIDE-BASED MEDICAMENT COMPOSITIONS AND DEVICES AND METHODS OF PRODUCTION AND USE THEREOF

#7024
20230338455
2023-10-26

PHARMACEUTICAL COMPOSITION IN THE FORM OF A HYDROGEL COMPRISING ORANGE-DERIVED EXTRACELLULAR VESICLES

#7025
20230338449
2023-10-26

PLANT EXTRACTS WITH ANTI-DIABETIC AND OTHER USEFUL ACTIVITIES

#7026
20230338445
2023-10-26

Oncolytic viruses for modified MHC expression

#7027
20230338437
2023-10-26

METHOD FOR TREATING AND/OR PREVENTING A PARASITIC INFECTION IN A TELEOST

#7028
20230338415
2023-10-26

SUBSTITUTED PHENYL BORONIC ACID CONTAINING POLYMERS AND METHODS OF USE

#7029
20230338412
2023-10-26

METHOD OF USING CYCLODEXTRIN

#7030
20230338407
2023-10-26

COMPOSITIONS AND METHODS OF TREATMENT USING NICOTINAMIDE MONONUCLEOTIDE

#7031
20230338404
2023-10-26

METHODS FOR DECREASING THE INCIDENCE OF NECROTIZING ENTEROCOLITIS IN INFANTS, TODDLERS, OR CHILDREN USING HUMAN MILK OLIGOSACCHARIDES

#7032
20230338391
2023-10-26

TREATMENT FOR DEPRESSION

#7033
20230338386
2023-10-26

DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION

#7034
20230338385
2023-10-26

NOVEL USES

#7035
20230338376
2023-10-26

AMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE THEREOF

#7036
20230338374
2023-10-26

MDM2 INHIBITORS FOR USE IN THE TREATMENT OR PREVENTION OF HEMATOLOGIC NEOPLASM RELAPSE AFTER HEMATOPOIETIC CELL TRANSPLANTATION

#7037
20230338369
2023-10-26

COMBINATION OF A PROTEASOME INHIBITOR AND A HDAC INHIBITOR AND ITS USE FOR THE TREATMENT OF GENETIC DISEASES LINKED TO A PROTEIN CONFORMATIONAL DISORDER

#7038
20230338367
2023-10-26

TREATMENT OF PRURIGO NODULARIS

#7039
20230338363
2023-10-26

COMBINATION CHEMO-IMMUNOTHERAPY FOR PANCREATIC CANCER USING THE IMMUNOGENIC EFFECTS OF AN IRINOTECAN SILICASOME NANOCARRIER PLUS ANTI-PD-1

#7040
20230338362
2023-10-26

METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS

#7041
20230338360
2023-10-26

Method of Inhibiting Constitutively Active Phosphorylated FLT3 Kinase

#7042
20230338351
2023-10-26

Androgen Receptor Inhibitors For The Treatment Of Non-Metastatic Castration-Resistant Prostate Cancer In Subjects With Severe Hepatic Impairment

#7043
20230338343
2023-10-26

NOVEL ANTI-AGING AGENTS AND METHODS TO IDENTIFY THEM

#7044
20230338340
2023-10-26

Methods of Treating Cystic Fibrosis

#7045
20230338335
2023-10-26

ORAL DISSOLVABLE FILM THAT INCLUDES PLANT EXTRACT

#7046
20230338333
2023-10-26

Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders

#7047
20230338328
2023-10-26

KOJIC ACID DERIVATIVE AS SELECTIVE INHIBITOR OF MITOSIS IN COLORECTAL AND GLIOBLASTOMA CANCER CELLS

#7048
20230338323
2023-10-26

METHODS OF REDUCING THE RISK OF A CARDIOVASCULAR EVENT IN A SUBJECT ON STATIN THERAPY

#7049
20230338319
2023-10-26

Compositions and methods for stimulating ventilatory and/or respiratory drive

#7050
20230338315
2023-10-26

METHOD OF PRODUCING PHARMACEUTICAL COCRYSTALS FOR ADDITIVE MANUFACTURING

#7051
20230338314
2023-10-26

METHODS FOR THE TREATMENT OF MYELOID DERIVED SUPPRESSOR CELLS RELATED DISORDERS

#7052
20230338312
2023-10-26

Methods of treatment of cholestatic diseases

#7053
20230338310
2023-10-26

ANTI-VIRAL THERAPY

#7054
20230338297
2023-10-26

Encapsulated Agents that Bind to MCT-1

#7055
20230338292
2023-10-26

Biodegradable polymer microsphere compositions for parenteral administration

#7056
20230338291
2023-10-26

Therapeutic constructs for co-delivery of mitotic kinase inhibitor and immune checkpoint inhibitor

#7057
20230338286
2023-10-26

Single solution hydrogels with covalent bonding formed in situ, composition design and medical procedures using the hydrogels

#7058
20230338275
2023-10-26

Method and Formulation for Improving Roflumilast Skin Penetration Lag Time

#7059
20230338251
2023-10-26

METHOD OF TREATING CANCER

#7060
20230333126
2023-10-19

MARKERS FOR DETECTING CARDIOVASCULAR DISEASE AND CARDIOVASCULAR DISEASE RISK

#7061
20230332153
2023-10-19

Modified Short Interfering Nucleic Acid (siNA) Molecules and Uses Thereof

#7062
20230332128
2023-10-19

MODIFIED BETA-LACTAMASES AND METHODS AND USES RELATED THERETO

#7063
20230331988
2023-10-19

POLYLYSINE POLYMERS WITH ANTIMICROBIAL AND/OR ANTICANCER ACTIVITY

#7064
20230331860
2023-10-19

Method of Treating an Autoimmune Disease with Antagonistic CD40 Monoclonal Antibodies

#7065
20230331854
2023-10-19

METHODS AND COMPOSITIONS FOR TREATING SYSTEMIC MASTOCYTOSIS

#7066
20230331837
2023-10-19

OLIGONUCLEOTIDES FOR REDUCTION OF PD-L1 EXPRESSION

#7067
20230331831
2023-10-19

Methods of treating AL amyloidosis

#7068
20230331825
2023-10-19

SARS-COV-2 ASSOCIATED ANTIBODY COMPOSITIONS AND METHODS OF USE

#7069
20230331797
2023-10-19

HLA-A24 AGONIST EPITOPES OF MUC1-C ONCOPROTEIN AND COMPOSITIONS AND METHODS OF USE

#7070
20230331795
2023-10-19

ENGINEERING IMMUNE CHECKPOINT BLOCKADE NANOBODY-STING DELTA-TM FUSION PROTEIN AS A VERSATILE TREATMENT FOR SOLID TUMOR CANCERS

#7071
20230331780
2023-10-19

COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALZHEIMER'S DISEASE

#7072
20230331761
2023-10-19

Aryl Glucoside Derivative, Preparation Method Therefor And Application Thereof

#7073
20230331728
2023-10-19

Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use

#7074
20230331724
2023-10-19

Processes for preparing a diazabicyclooctane compound

#7075
20230331712
2023-10-19

SOLID FORMS OF (R)-1(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL)-N-(1-(2,3-DIHYDROXYPROPYL)-6-FLUORO-2-(1-HYDROXY-2-METHYLPROPAN-2-YL)-1H-INDOL-5-YL)CYCLOPROPANECARBOXAMIDE

#7076
20230331711
2023-10-19

CRYSTALLINE PHARMACEUTICAL AND METHODS OF PREPARATION AND USE THEREOF

#7077
20230331705
2023-10-19

Fused Imidazole Derivatives as AHR Antagonists

#7078
20230331694
2023-10-19

FAP-ACTIVATED COMPOUNDS FOR TREATMENT OF CANCER

#7079
20230331693
2023-10-19

GSPT1 compounds and methods of use of the novel compounds

#7080
20230331691
2023-10-19

Treprostinil derivative compounds and methods of using same

#7081
20230331681
2023-10-19

Compounds and methods for the targeted degradation of androgen receptor

#7082
20230331679
2023-10-19

NAPHTHALENE MONOIMIDE COMPOUNDS AND METHODS THEREOF

#7083
20230331675
2023-10-19

AROMATIC ETHYLENE COMPOUND AND PREPARATION METHOD THEREFOR, AND INTERMEDIATE, PHARMACEUTICAL COMPOSITION, AND APPLICATION THEREOF

#7084
20230330259
2023-10-19

COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR RELATED DISORDERS

#7085
20230330237
2023-10-19

MODULATORS OF NUCLEAR RECEPTOR SUBFAMILY 4 GROUP A MEMBER 1 (NR4A1) AND USES THEREOF

#7086
20230330232
2023-10-19

SELF-ASSEMBLED COMPLEX CONTAINING IRON ION

#7087
20230330231
2023-10-19

Process for cure of MI's and strokes through drug induced biophysical methods.

#7088
20230330200
2023-10-19

NY-ESO-1-CONTAINING ARTIFICIAL ADJUVANT VECTOR CELL FOR USE IN TREATMENT OF CANCER

#7089
20230330193
2023-10-19

ENHANCEMENT OF STEM CELL THERAPY FOR CARTILAGE DEGENERATION BY ANTI-OXIDANT PRE-CONDITIONING

#7090
20230330187
2023-10-19

USE OF GHRELIN OR GHRELIN VARIANT FOR INCREASING DOSE INTENSITY OF CHEMOTHERAPEUTIC AGENTS IN PATIENTS WITH CANCER

#7091
20230330178
2023-10-19

USE OF POLYPEPTIDE IN DRUG FOR PREVENTING AND TREATING PNEUMONIA

#7092
20230330176
2023-10-19

PHARMACEUTICAL COMBINATION COMPRISING AN IBAT INHIBITOR AND A BILE ACID BINDER

#7093
20230330171
2023-10-19

BOYSENBERRY COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREOF

#7094
20230330169
2023-10-19

PHARMACEUTICAL COMPOSITIONS

#7095
20230330159
2023-10-19

COMPOSITION FOR DIAGNOSIS OR TREATMENT OF INFLAMMATORY DISEASES, COMPRISING MICROORGANISM

#7096
20230330156
2023-10-19

Biopolymer compositions for the treatment and prevention of gastric ulcers

#7097
20230330155
2023-10-19

FOLLICULAR FLUID METHOD

#7098
20230330145
2023-10-19

NATURAL KILLER CELLS

#7099
20230330134
2023-10-19

METHOD OF PROPHYLAXIS OF CORONAVIRUS AND/OR RESPIRATORY SYNCYTIAL VIRUS INFECTION

#7100
20230330119
2023-10-19

Methods for treating pulmonary non-tuberculous mycobacterial infections

#7101
20230330116
2023-10-19

MATERIALS AND METHODS FOR SUPPRESSING AND/OR TREATING BONE RELATED DISEASES AND SYMPTOMS

#7102
20230330112
2023-10-19

COMPOSITION AND TREATMENT FOR CANCER WITH MUTATIONS

#7103
20230330111
2023-10-19

ACTIVE AGENT COMBINATION FOR TREATMENT OF CANCER

#7104
20230330099
2023-10-19

Substituted indole Mcl-1 inhibitors

#7105
20230330086
2023-10-19

Antiproliferative compounds and second active agents for combined use

#7106
20230330084
2023-10-19

Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

#7107
20230330083
2023-10-19

COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING PULMONARY HYPERTENSION

#7108
20230330075
2023-10-19

Methods for treating chronic obstructive pulmonary disease

#7109
20230330071
2023-10-19

METHODS OF TREATING HEPATIC ENCEPHALOPATHY

#7110
20230330058
2023-10-19

SENOLYTIC COMPOUNDS AND COMPOSITIONS

#7111
20230330056
2023-10-19

SEMIFLUORINATED ALKANE COMPOSITIONS

#7112
20230330051
2023-10-19

METHOD FOR MODULATING WEIGHT

#7113
20230330048
2023-10-19

Methods of treatment of cholestatic diseases

#7114
20230330046
2023-10-19

TARGETING OCULAR DISEASES WITH NOVEL APE1/REF-1 INHIBITORS

#7115
20230330045
2023-10-19

THE ANTIVIRAL DRUG TILORONE IS A POTENT AND SELECTIVE INHIBITOR OF ACETYLCHOLINESTERASE

#7116
20230330015
2023-10-19

Levodopa infusion solution

#7117
20230330005
2023-10-19

SELF-ASSEMBLED COMPLEX CONTAINING CALCIUM ION

#7118
20230329304
2023-10-19

METABOLIC THERAPY OF CANCER

#7119
20230324392
2023-10-12

METHODS AND COMPOSITIONS FOR TARGETING CYTOSOLIC DSDNA SIGNALING IN CHROMOSOMALLY UNSTABLE CANCERS

#7120
20230323485
2023-10-12

METHOD FOR DETERMINING A VIRALLY-INFECTED SUBJECT'S RISK OF DEVELOPING SEVERE SYMPTOMS

#7121
20230323466
2023-10-12

DETERMINING CANCER RESPONSIVENESS TO TREATMENT

#7122
20230323460
2023-10-12

DETECTION AND TREATMENT OF AUTISM SPECTRUM DISORDERS

#7123
20230323402
2023-10-12

Targeted Gene Therapies for Pain and Other Neuro-Related Disorders

#7124
20230323368
2023-10-12

NOVEL TLR9 AGONISTS

#7125
20230322951
2023-10-12

Bi-Specific Fusion Proteins

#7126
20230322942
2023-10-12

METHODS FOR TREATING MULTIPLE SCLEROSIS WITH OCRELIZUMAB

#7127
20230322936
2023-10-12

IL10 receptor binding molecules and methods of use

#7128
20230322935
2023-10-12

ANTI-CD93 CONSTRUCTS AND USES THEREOF

#7129
20230322927
2023-10-12

EGFR x CD28 MULTISPECIFIC ANTIBODIES

#7130
20230322920
2023-10-12

MULTI-SPECIFIC ANTIBODIES AND METHODS OF MAKING AND USING THEREOF

#7131
20230322907
2023-10-12

ANTI-PCRV ANTIBODIES THAT BIND PCRV, COMPOSITIONS COMPRISING ANTI-PCRV ANTIBODIES, AND METHODS OF USE THEREOF

#7132
20230322813
2023-10-12

COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS

#7133
20230322777
2023-10-12

N1-Pyrazolospiroketone Acetyl-CoA Carboxylase Inhibitors

#7134
20230322771
2023-10-12

HETEROCYCLIC GLP-1 AGONISTS

#7135
20230322767
2023-10-12

ARYL SUBSTITUTED PYRROLO-PYRIDINONES AND THERAPEUTIC USES THEREOF

#7136
20230322726
2023-10-12

QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS

#7137
20230322722
2023-10-12

MODULATORS OF MYC FAMILY PROTO-ONCOGENE PROTEIN

#7138
20230322695
2023-10-12

Inhibitors of protein tyrosine phosphatase, compositions, and methods of use

#7139
20230322684
2023-10-12

COMPOSITIONS AND METHODS OF MODULATING SHORT-CHAIN DEHYDROGENASE

#7140
20230322574
2023-10-12

SURFACE-TREATED HYDROTALCITE, SUSPENSION OF SAME, AND FUNCTIONAL MOLECULE DELIVERY SYSTEM USING SAME

#7141
20230321286
2023-10-12

PROTOCOL FOR MINIMIZING TOXICITY OF COMBINATION DOSAGES AND IMAGING AGENT FOR VERIFICATION

#7142
20230321276
2023-10-12

NUCLEIC ACID THERAPY FOR DIFFERENTIAL MODULATION OF HOST MICROFLORA

#7143
20230321271
2023-10-12

ANTI-cMet ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE

#7144
20230321261
2023-10-12

AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT

#7145
20230321253
2023-10-12

BIFUNCTIONAL COMPOUNDS AND PHARMACEUTICAL USES THEREOF

#7146
20230321232
2023-10-12

METHODS OF TREATING GENERALIZED PUSTULAR PSORIASIS (GPP) USING IL-17 ANTAGONISTS

#7147
20230321209
2023-10-12

MODIFIED MYCOBACTERIUM BOVIS VACCINES

#7148
20230321208
2023-10-12

TRANSFECTED T-CELLS AND T-CELL RECEPTORS FOR USE IN IMMUNOTHERAPY AGAINST CANCERS

#7149
20230321199
2023-10-12

USES OF PTHrP ANALOGUE IN REDUCING FRACTURE RISK

#7150
20230321190
2023-10-12

PHARMACEUTICAL AND COSMETIC COMPOSITIONS COMPRISING SECRETOMES

#7151
20230321189
2023-10-12

THERAPEUTIC AGENTS, PHARMACEUTICAL COMPOSITIONS, AND ASSOCIATED BIOMARKERS BASED ON TRK-B

#7152
20230321177
2023-10-12

POLYPHARMACEUTICAL DRUG COMPOSITIONS AND RELATED METHODS

#7153
20230321167
2023-10-12

COMPOSITIONS AND METHODS FOR TREATMENT OF CANCERS

#7154
20230321162
2023-10-12

MICROBIAL STRAINS AND ANTIBIOTICS

#7155
20230321158
2023-10-12

COMPOSITIONS FOR PROTECTION AGAINST PATHOGEN INFECTION AND METHOD THEREOF

#7156
20230321152
2023-10-12

CYTOKINE STORM SUPPRESSOR, METHOD FOR USING CYTOKINE STORM SUPPRESSOR AND SCREENING METHOD

#7157
20230321136
2023-10-12

COMPOSITION AND METHOD OF APPLYING SAME TO INCREASE SURVIVAL OF FISH FOLLOWING CATCH-AND-RELEASE SITUATIONS

#7158
20230321131
2023-10-12

NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES AND USE THEREOF IN THE TREATMENT AND PREVENTION OF AN ANTINEOPLASTIC-INDUCED TOXICITY

#7159
20230321126
2023-10-12

Micronutrient combination to inhibit coronavirus cell infection

#7160
20230321125
2023-10-12

COMPOSITIONS OF GINSENOSIDE RG3 AND GINSENOSIDE RG5 AND THEIR PHARMACEUTICAL USES INCLUDING ANTI-TUMOR EFFECTS

#7161
20230321123
2023-10-12

INHIBITORS OF PSEUDOMONAS AERUGINOSA VIRULENCE FACTOR LasB

#7162
20230321109
2023-10-12

PHARMACEUTICAL COMPOSITIONS COMPRISING MACROLIDE DIASTEREOMERS, METHODS OF THEIR SYNTHESIS AND THERAPEUTIC USES

#7163
20230321107
2023-10-12

Therapeutically active compounds and their methods of use

#7164
20230321097
2023-10-12

METHODS AND COMPOSITIONS FOR TREATING ABNORMAL CELL GROWTH

#7165
20230321094
2023-10-12

COMBINATION THERAPIES WITH OLIG2 INHIBITORS

#7166
20230321091
2023-10-12

SUBSTITUTED PYRIDAZINONES FOR USE IN THE TREATMENT OF NEUROMUSCULAR DISEASES

#7167
20230321085
2023-10-12

COMPOUND FOR USE IN THE TREATMENT OF DRY MOUTH

#7168
20230321081
2023-10-12

MASITINIB FOR THE TREATMENT OF CASTRATE-RESISTANT PROSTATE CANCER

#7169
20230321073
2023-10-12

COMPOSITIONS AND METHODS FOR TREATING METABOLIC DYSREGULATION

#7170
20230321071
2023-10-12

Eye-soothing Externally-applied Liquid Medicine and Preparation Method Therefor

#7171
20230321067
2023-10-12

DOSING REGIMEN COMPRISING 3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES

#7172
20230321066
2023-10-12

PREVENTATIVE TREATMENT OF MIGRAINE

#7173
20230321063
2023-10-12

COMPOSITIONS AND METHODS TO REDUCE NEUROINFLAMMATION

#7174
20230321057
2023-10-12

TOPICAL ROFLUMILAST FORMULATION HAVING ANTIFUNGAL PROPERTIES

#7175
20230321053
2023-10-12

(1R,3S)-3-((5-CYANO-4-PHENYLTHIAZOL-2-YL)CARBAMOYL)CYCLOPENTANE-1-CARBOXYLIC ACID AND DERIVATIVES THEREOF FOR USE IN THE TREATMENT OF AIRWAY DISEASES

#7176
20230321052
2023-10-12

ALPHA-AMINO ESTERS OF HYDROXYPROPYLTHIAZOLIDINE CARBOXAMIDE DERIVATIVE AND SALT FORM, CRYSTAL POLYMORPH THEREOF

#7177
20230321048
2023-10-12

ANTIBODY DRUG CONJUGATES COMPRISING STING AGONISTS

#7178
20230321035
2023-10-12

Lasofoxifene treatment of aromatase-resistant ER+cancer

#7179
20230321034
2023-10-12

Short-acting psychoactive compounds of the MDMA class

#7180
20230321027
2023-10-12

ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE

#7181
20230321023
2023-10-12

APPLICATION OF REGULATION OF EYE SCLERA LIPID METABOLISM TO INHIBIT MYOPIA

#7182
20230321021
2023-10-12

METHODS OF NORMALIZING AMINO ACID METABOLISM

#7183
20230321017
2023-10-12

ACIDIC CANNABINOIDS AND USES THEREOF FOR ENHANCING FEMALE SEXUAL FUNCTION OR TREATING FEMALE SEXUAL DISORDERS

#7184
20230321014
2023-10-12

Mirdametinib treatment

#7185
20230321007
2023-10-12

PHARMACOKINETICS OF NMDA RECEPTOR ANTAGONISTS

#7186
20230320997
2023-10-12

MAGNETOELECTRIC NANOCOMPOSITES AND METHOD OF PREPARATION THEREOF

#7187
20230320992
2023-10-12

SEQUENTIAL ADMINISTRATION OF PARTITIONED ABSORPTION ASPIRIN OR ACTIVE ASPIRIN DERIVATIVE AND COX-2 INHIBITOR

#7188
20230320981
2023-10-12

SOLID ORAL PHARMACEUTICAL COMPOSITIONS FOR ISOXAZOLINE COMPOUNDS

#7189
20230314441
2023-10-05

DIAGNOSIS AND TREATMENT OF CANCER

#7190
20230314425
2023-10-05

METHODS AND MATERIALS FOR IDENTIFYING AND TREATING MEMBRANOUS NEPHROPATHY

#7191
20230313166
2023-10-05

BETA-LACTAMASES WITH IMPROVED PROPERTIES FOR THERAPY

#7192
20230313143
2023-10-05

MULTIFUNCTIONAL IMMATURE DENTAL PULP STEM CELLS AND THERAPEUTIC APPLICATIONS

#7193
20230312837
2023-10-05

POLYMERS AND USES THEREOF

#7194
20230312822
2023-10-05

PROCESS FOR THE PREPARATION OF ALKOXYLATES COMPOSITIONS

#7195
20230312730
2023-10-05

Compositions and methods comprising anti-NRP2 antibodies

#7196
20230312716
2023-10-05

CD33-binding polypeptides and uses thereof

#7197
20230312703
2023-10-05

Method of Treating Psoriasis with IL-23 Specific Antibody

#7198
20230312677
2023-10-05

CD28 COMPOSITIONS AND METHODS FOR CHIMERIC ANTIGEN RECEPTOR THERAPY

#7199
20230312597
2023-10-05

NOVEL COMPOUNDS WITH ANTIBACTERIAL AND ANTI VIRAL ACTIVITIES

#7200
20230312588
2023-10-05

IMIDAZOPIPERAZINE INHIBITORS OF TRANSCRIPTION ACTIVATING PROTEINS